Loading…
Roivant Sciences Ltd. is projected to rise to $49.55 by 2027, a +39% move from its current price of $35.76. ROIV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $35.14 | $35.76 | $36.39 | -0.01% |
| Jul 13 | $34.88 | $35.76 | $36.66 | -0.01% |
| Jul 14 | $34.68 | $35.76 | $36.86 | -0.02% |
| Jul 15 | $34.52 | $35.75 | $37.03 | -0.02% |
| Jul 16 | $34.37 | $35.75 | $37.19 | -0.03% |
| Jul 17 | $34.24 | $35.75 | $37.32 | -0.03% |
| Jul 18 | $34.12 | $35.75 | $37.45 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $34.12 | $35.75 | $37.45 | -0.04% |
| Week 2 | $33.46 | $35.73 | $38.17 | -0.08% |
| Week 3 | $32.95 | $35.72 | $38.72 | -0.11% |
| Week 4 | $32.53 | $35.71 | $39.19 | -0.15% |
| Week 5 | $32.16 | $35.69 | $39.61 | -0.19% |
| Week 6 | $31.83 | $35.68 | $39.99 | -0.23% |
| Week 7 | $31.53 | $35.67 | $40.34 | -0.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Roivant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of medicines and technologies. It operates in the Healthcare sector and has a portfolio that includes mosliciguat, IMVT-1402, and other clinical product candidates such as the neonatal fragment crystallizable receptor, batoclimab, and brepocitinib.
The company also highlights its delivery platforms, comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Roivant Sciences Ltd. (ROIV) currently trades at $36.81 with a market capitalization of $26.48B, and it ranks 504 by market cap. The current price places the stock among mid-large cap healthcare names with a global footprint.
A major floor 29.8% below — a decisive break under it would weaken the trend.
The nearest floor, 21.0% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key ROIV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ROIV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.11 | Sell | $36.01 | Sell |
| MA 10 | $35.49 | Buy | $35.30 | Buy |
| MA 20 | $33.46 | Buy | $33.89 | Buy |
| MA 50 | $30.82 | Buy | $31.58 | Buy |
| MA 100 | $29.54 | Buy | $29.27 | Buy |
| MA 200 | $25.01 | Buy | $25.51 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.33 | Neutral |
| Stoch RSI (14) | 50.12 | Neutral |
| CCI (20) | 78.12 | Neutral |
| Williams %R (14) | -15.11 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | 11.67 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 84.89 | Sell |
| TRIX (15) | 0.72 | Buy |
| Awesome (5,34) | 4.37 | Buy |
| Ultimate (7,14,28) | 65.89 | Neutral |
| Momentum (10) | 1.95 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 36.67 | Sell |
| ADX (14) | 34.08 | Buy |
| ATR (14) | 0.56 | Info |
The 30-day technical picture is bullish, with RSI(14) at 80, indicating strong momentum. The stock trades above its short-term and longer-term moving averages, with a SMA50 of $30.66 and a SMA200 of $24.91. Key levels to watch are support at $28.25 and resistance at $36.81, with a 30-day price range between $32.83 and $41.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.14 | $35.76 | $46.07 | 0% | Neutral | |
| $40.58 | $49.55 | $63.25 | +39% | Bullish | |
| $51.73 | $64.35 | $84.37 | +80% | Bullish | |
| $57.50 | $72.63 | $97.26 | +103% | Bullish | |
| $66.20 | $84.76 | $115.54 | +137% | Bullish | |
| $73.29 | $94.98 | $131.51 | +166% | Bullish | |
| $79.32 | $103.95 | $145.99 | +191% | Bullish | |
| $91.50 | $121.17 | $172.37 | +239% | Bullish | |
| $110.50 | $147.79 | $212.76 | +313% | Bullish | |
| $127.57 | $172.23 | $250.70 | +382% | Bullish | |
| $197.58 | $278.22 | $424.40 | +678% | Bullish | |
| $349.90 | $528.44 | $864.06 | +13.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $21.14 | $35.76 | $43.03 | +0.00% |
| August 2026 | $30.96 | $36.24 | $43.35 | +1.34% |
| September 2026 | $30.25 | $35.58 | $42.89 | -1.81% |
| October 2026 | $30.73 | $36.29 | $44.04 | +2.00% |
| November 2026 | $31.57 | $37.42 | $45.65 | +3.10% |
| December 2026 | $31.60 | $37.57 | $46.07 | +0.40% |
Click any year to see its month-by-month ROIV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ROIV to range from $21.14 to $46.07 through 2026. The $35.76 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ROIV price prediction for 2027 points to an average of $49.55 (low $40.58, high $63.25) — a potential gain of +39% on today's $35.76. Momentum favours further upside here.
In 2028, ROIV is projected to trade between $51.73 and $84.37, averaging $64.35 — a potential gain of +80% from today's $35.76. That is up +30% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Roivant Sciences Ltd.'s 2029 outlook centres on $72.63, within a $57.50 to $97.26 range. That is up +13% on the projected 2028 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2030, ROIV could reach as high as $115.54, with a base case around $84.76 and support toward $66.20 — roughly +137% from $35.76. Buyers look set to stay in control over this stretch.
Expect ROIV to range from $73.29 to $131.51 through 2031. The $94.98 average target implies a +166% move from current prices. That is up +12% on the projected 2030 average. Momentum favours further upside here.
The ROIV price prediction for 2032 points to an average of $103.95 (low $79.32, high $145.99) — a potential gain of +191% on today's $35.76. Buyers look set to stay in control over this stretch.
In 2033, ROIV is projected to trade between $91.50 and $172.37, averaging $121.17 — a potential gain of +239% from today's $35.76. That is up +17% on the projected 2032 average. Momentum favours further upside here.
Roivant Sciences Ltd.'s 2034 outlook centres on $147.79, within a $110.50 to $212.76 range. That is up +22% on the projected 2033 average. That marks a +313% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ROIV could reach as high as $250.70, with a base case around $172.23 and support toward $127.57 — roughly +382% from $35.76. Momentum favours further upside here.
Expect ROIV to range from $197.58 to $424.40 through 2040. The $278.22 average target implies a +678% move from current prices. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ROIV price prediction for 2050 points to an average of $528.44 (low $349.90, high $864.06) — a potential gain of +13.8x on today's $35.76. Momentum favours further upside here.
Investing $1,000 in ROIV today (≈ 27.962642 ROIV) could be worth
$14,776.65
+$13,776.65 (+1378%) by 2050 · US Dollar
Based on the average projected ROIV price of $528.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ROIVwould be worth at today's price.
$1,000 invested in ROIV on Jul 10, 2025 (≈ 86.430426 ROIV) would be worth
$3,090.92
+$2,090.92 (+209.1%) today · 3.09× · US Dollar
Based on a ROIV entry price of $11.57 vs. today's $35.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $35.13 | $1,017.99 | +1.8% |
| 1 month ago | $28.41 | $1,258.78 | +25.9% |
| 3 months ago | $28.21 | $1,267.71 | +26.8% |
| 6 months ago | $22.16 | $1,613.81 | +61.4% |
| 1 year ago | $11.57 | $3,090.92 | +209.1% |
| All time (5.0y) ago | $9.91 | $3,608.68 | +260.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ROIV forecast.
Our base-case forecast reaches $72.00 around 2029.
Implied market cap at $72.00: $51.79B
Multi-year forecasts show a rising trajectory. In 2026, the avg price is $36.81 with min $21.14 and max $47.38 (ROI 0) and sentiment NEUTRAL. The 2027 forecast shows an avg of $50.92 (min $41.70, max $65.01; ROI 38.3%, sentiment BULLISH), rising further in 2028 to an avg of $65.98 (min $53.03, max $86.51; ROI 79.2%), and in 2029 to an avg of $74.26 (min $58.79, max $99.45; ROI 101.8%).
By 2030 the avg is $86.68 (min $67.71, max $118.17; ROI 135.5%), and the growth continues through 2031–2035 with avg prices of $96.97, $105.85, $123.53, $150.46, and $174.95 respectively (ROI 163.4%, 187.6%, 235.6%, 308.8%, 375.3%). The forecast for 2040 shows an avg of $281.89 (min $200.18, max $430.01; ROI 665.8%), and by 2050 the avg climbs to $533.65 (min $353.34, max $872.58; ROI 1349.7%), with sentiment remaining BULLISH.
Tap a question to reveal the answer.
Avg $86.68; min $67.71; max $118.17; ROI 135.5%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with 2027 avg $50.92, 2028 avg $65.98, 2029 avg $74.26, 2030 avg $86.68, 2035 avg $174.95, and 2050 avg $533.65; ROI up to 1349.7%.
Yes. The 2040 forecast shows an avg of $281.89, min $200.18, max $430.01, ROI 665.8%, with sentiment BULLISH.
The current price is $36.81.
The 30-day range is $32.83 to $41.27; RSI(14) is 80; SMA50 is $30.66; SMA200 is $24.91; support is $28.25 and resistance is $36.81; annualized volatility is 30%.
Roivant Sciences Ltd. Community Discussion
0Share your Roivant Sciences Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.